BRESSNER GLEN R

SEC source: 0001179110-17-015259 · edgar.xml · nonDerivative · entry 3

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Originate Growth Fund #1A, L.P.

Disclosed balance after: 629,594

F3 · price: Represents shares of the Company's common stock sold by Originate Growth Fund #1A, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.

F5 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001179110-17-015259 · edgar.xml · nonDerivative · entry 1

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By: Originate Growth Fund #1Q, L.P.

Disclosed balance after: 1,390,273

F1 · price: Represents shares of the Company's common stock sold by Originate Growth Fund #1Q, L.P. in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.

F5 · ownership.direct: The general partner of Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. is Originate Growth GP, LLC. The members of Originate Growth GP, LLC are Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The members of Originate Growth GP, LLC share voting and dispositive power over the shares held by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P. Mr. Bressner disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001179110-17-015258 · edgar.xml · nonDerivative · entry 1

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 629,594

F1 · price: Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.

F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.

SEC source: 0001179110-17-015256 · edgar.xml · nonDerivative · entry 1

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,390,273

F1 · price: Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.

F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.

SEC source: 0001192482-18-000108 · edgar.xml · nonDerivative · entry 1

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · Former 10% owner

Originate Growth GP, LLC · CIK 0001685914 · Former 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · Former 10% owner

Arnson Eric R · CIK 0001685942 · Former 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · Former 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 629,594

F1 · price: Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.

F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.

SEC source: 0001192482-18-000107 · edgar.xml · nonDerivative · entry 1

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · Former 10% owner

Originate Growth GP, LLC · CIK 0001685914 · Former 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · Former 10% owner

Arnson Eric R · CIK 0001685942 · Former 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · Former 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,390,723

F1 · price: Represents shares of the Company's common stock sold by the Reporting Person in an underwritten public offering completed on December 8, 2017 at a price per share of $25.85, after deducting underwriting discounts and commissions of $1.65 per share.

F3 · ownership.direct: This report is filed jointly by Originate Growth Fund #1Q, L.P. ("Originate #1Q"), Originate Growth GP, LLC ("Originate GP"), Glen R. Bressner, Eric R. Arnson and Michael J. Gausling. The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Messrs. Bressner, Arnson and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest. In addition, 5,565 shares granted to Mr. Bressner in September 2016 and 2,596 shares granted to Mr. Bressner in June 2017 are beneficially owned by Originate Growth Fund #1Q, L.P. and Originate Growth Fund #1A, L.P., with the shares allocated to each fund on a pro rata basis.

SEC source: 0001192482-17-000172 · edgar.xml · nonDerivative · entry 1

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,161

F1 · balance_after: Glen Bressner received a restricted stock award of 2,596 shares of the Company's common stock on June 16, 2017. Such common stock vests in full on the earlier of the next annual shareholder meeting or the one year anniversary of the date of grant.

SEC source: 0001192482-17-000128 · edgar.xml · nonDerivative · entry 2

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,565

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.96 to $11.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001192482-17-000128 · edgar.xml · nonDerivative · entry 1

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,256

F1 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.90 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0001179110-17-000984 · edgar.xml · derivative · entry 2

BRESSNER GLEN R · CIK 0000902959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,234 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: The restricted stock units were granted on November 12, 2015 as compensation for service on the Issuer's board of directors during the year ended December 31, 2016 and vested in full on January 2, 2017.

F2 · derivative.expiration_date: The restricted stock units were granted on November 12, 2015 as compensation for service on the Issuer's board of directors during the year ended December 31, 2016 and vested in full on January 2, 2017.

SEC source: 0001179110-17-000984 · edgar.xml · nonDerivative · entry 1

BRESSNER GLEN R · CIK 0000902959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,182

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represented a contingent right to receive one share of the Issuer's common stock.

SEC source: 0001192482-16-000718 · edgar.xml · derivative · entry 6

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 119,055 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F1 · price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F3 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F3 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000718 · edgar.xml · derivative · entry 5

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 668,353 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F1 · price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F3 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F3 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000718 · edgar.xml · derivative · entry 4

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,043,510 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F1 · price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F3 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F3 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000718 · edgar.xml · nonDerivative · entry 3

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,914,078

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000718 · edgar.xml · nonDerivative · entry 2

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,795,023

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000718 · edgar.xml · nonDerivative · entry 1

ORIGINATE GROWTH FUND 1Q LP · CIK 0001384605 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,126,670

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Originate Growth Fund #1Q, L.P. ("Originate #1Q") was the record holder of 2,024,410 shares of Series A Preferred Stock, which automatically converted into 1,043,510 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 1,296,605 shares of Series A-1 Preferred Stock, which automatically converted into 668,353 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1Q was the record holder of 230,968 shares of Series B Preferred Stock, which automatically converted into 119,055 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1Q, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1Q. The general partner of Originate #1Q is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000723 · edgar.xml · derivative · entry 6

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 53,912 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F1 · price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F3 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F3 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000723 · edgar.xml · derivative · entry 5

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 302,659 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F1 · price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F3 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F3 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000723 · edgar.xml · derivative · entry 4

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 472,560 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F1 · price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F3 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F3 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000723 · edgar.xml · nonDerivative · entry 3

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 866,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000723 · edgar.xml · nonDerivative · entry 2

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 812,877

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000723 · edgar.xml · nonDerivative · entry 1

ORIGINATE GROWTH FUND 1A LP · CIK 0001384604 · 10% owner

Originate Growth GP, LLC · CIK 0001685914 · 10% owner

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

Arnson Eric R · CIK 0001685942 · 10% owner

GAUSLING MICHAEL J · CIK 0001125761 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 510,218

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Originate Growth Fund #1A, L.P. ("Originate #1A"), Originate #1A was the record holder of 916,766 shares of Series A Preferred Stock, which automatically converted into 472,560 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 587,158 shares of Series A-1 Preferred Stock, which automatically converted into 302,659 shares of common stock upon the closing of the Issuer's initial public offering. Originate #1A was the record holder of 104,589 shares of Series B Preferred Stock, which automatically converted into 53,912 shares of common stock upon the closing of the Issuer's initial public offering.

F2 · ownership.direct: This report is filed jointly by Originate #1A, Originate Growth GP, LLC ("Originate GP"), Glen Bressner ("Bressner"), Eric Arnson ("Arnson"), and Michael Gausling ("Gausling"). The shares are held by Originate #1A. The general partner of Originate #1A is Originate GP, a limited liability company. The members of Originate GP are Bressner, Arnson, and Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1A. Each of these individuals disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000720 · edgar.xml · derivative · entry 8

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 172,967 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · derivative.exercise_price: and (h) 83,160 shares of common stock held by Originate #1Q.

F1 · price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · price: and (h) 83,160 shares of common stock held by Originate #1Q.

F5 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F5 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · derivative.underlying_shares: and (h) 83,160 shares of common stock held by Originate #1Q.

F3 · ownership.nature: The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000720 · edgar.xml · derivative · entry 7

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 971,012 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · derivative.exercise_price: and (h) 83,160 shares of common stock held by Originate #1Q.

F1 · price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · price: and (h) 83,160 shares of common stock held by Originate #1Q.

F5 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F5 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · derivative.underlying_shares: and (h) 83,160 shares of common stock held by Originate #1Q.

F3 · ownership.nature: The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000720 · edgar.xml · derivative · entry 6

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P.

Disclosed balance after: 0

Underlying: Common Stock · 1,516,070 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · derivative.exercise_price: and (h) 83,160 shares of common stock held by Originate #1Q.

F1 · price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · price: and (h) 83,160 shares of common stock held by Originate #1Q.

F5 · derivative.exercise_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F5 · derivative.expiration_date: All series of Preferred Stock automatically converted into Tabula Rasa HealthCare, Inc. (the "Issuer") common stock immediately prior to the closing of the initial public offering and have no expiration date.

F1 · derivative.underlying_shares: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · derivative.underlying_shares: and (h) 83,160 shares of common stock held by Originate #1Q.

F3 · ownership.nature: The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000720 · edgar.xml · nonDerivative · entry 5

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Son

Disclosed balance after: 2,794,932

F4 · ownership.nature: Represents shares held by Mr. Bressner's son. Mr. Bressner disclaims beneficial ownership of such shares.

SEC source: 0001192482-16-000720 · edgar.xml · nonDerivative · entry 4

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,793,932

SEC source: 0001192482-16-000720 · edgar.xml · nonDerivative · entry 3

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P.

Disclosed balance after: 2,786,432

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · price: and (h) 83,160 shares of common stock held by Originate #1Q.

F3 · ownership.nature: The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000720 · edgar.xml · nonDerivative · entry 2

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P.

Disclosed balance after: 2,613,465

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · price: and (h) 83,160 shares of common stock held by Originate #1Q.

F3 · ownership.nature: The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001192482-16-000720 · edgar.xml · nonDerivative · entry 1

BRESSNER GLEN R · CIK 0000902959 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Originate Growth Fund #1A, L.P. and Originate Growth Fund #1Q, L.P.

Disclosed balance after: 1,642,453

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The shares consist of (a) 472,560 shares of common stock issued upon the conversion of 916,766 shares of Series A preferred stock held by Originate Growth Fund #1A, L.P., ("Originate #1A"), (b) 1,043,510 shares of common stock issued upon the conversion of 2,024,410 shares of Series A preferred stock held by Originate Growth Fund #1Q, L.P., ("Originate #1Q"), (c) 302,659 shares of common stock issued upon the conversion of 587,158 shares of Series A-1 preferred stock held by Originate #1A, (d) 668,353 shares of common stock issued upon the conversion of 1,296,605 shares of Series A-1 preferred stock held by Originate #1Q, (e) 53,912 shares of common stock issued upon the conversion of 104,589 shares of Series B preferred stock held by Originate #1A, (f) 119,055 shares of common stock issued upon the conversion of 230,968 shares of Series B preferred stock held by Originate #1Q, (g) 37,658 shares of common stock held by Originate #1A, (CONTINUED IN FOOTNOTE 2)

F2 · price: and (h) 83,160 shares of common stock held by Originate #1Q.

F3 · ownership.nature: The general partner of both Originate #1Q and Originate #1A is Originate GP, LLC, a limited liability company. The members of Originate GP, LLC are Glen Bressner, Eric Arnson, and Michael Gausling. The members of Originate GP share voting and dispositive power over the shares held by Originate #1Q and Originate #1A. Mr. Gausling disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest.

SEC source: 0001179110-16-030422 · edgar.xml · derivative · entry 1

BRESSNER GLEN R · CIK 0000902959 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,234

Underlying: Common Stock · 14,234 shares

Expires not disclosed

F1 · security: Stock-based compensation for the year ending December 31, 2016.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F3 · derivative.exercise_date: The restricted stock units will vest in full on January 2, 2017, provided that if the Reporting Person resigns from the Issuer's board of directors prior to January 1, 2017 he will receive a pro rated number of shares based on the number of days served as a director during 2016.

F3 · derivative.expiration_date: The restricted stock units will vest in full on January 2, 2017, provided that if the Reporting Person resigns from the Issuer's board of directors prior to January 1, 2017 he will receive a pro rated number of shares based on the number of days served as a director during 2016.